MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/jamaneurol.2025.5614

Медицинская библиотека · JAMA neurology · 2026

Long-Term Outcomes and Recovery Trajectories in Out-of-Hospital Cardiac Arrest: A 2-Year Follow-Up of the Randomized Clinical TTM2 Trial.

Hultgren Malin, Blennow Nordström Erik, Ullén Susann, Nielsen Niklas, Dankiewicz Josef, Jakobsen Janus Christian, Heimburg Katarina, Moseby-Knappe Marion, Belohlávek Jan, Bohm Mattias, Cariou Alain, Eastwood Glenn, Friberg Hans, Grejs Anders M, Hammond Naomi, Hänggi Matthias, Hrecko Juraj, Iten Manuela, Keeble Thomas R, Leithner Christoph, Levin Helena, Mion Marco, Rylander Christian, Schrag Claudia, Thomas Matthew, Wise Matt P, Young Paul, Cronberg Tobias, Lilja Gisela

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

IMPORTANCE

Guidelines for temperature control following out-of-hospital cardiac arrest (OHCA) are based on trials with end points of 180 days or fewer.

OBJECTIVES

To investigate if targeted hypothermia, compared with targeted normothermia with early treatment of fever, affects functional outcome focusing on societal participation or cognitive functioning at 24 months in initially comatose OHCA survivors. An additional objective was to explore recovery trajectories up to 24 months post arrest.

DESIGN, SETTING, AND

PARTICIPANTS

The randomized clinical Targeted Hypothermia vs Targeted Normothermia After OHCA (TTM2) trial (November 2017-2020) included blinded follow-up at 1, 6, and 24 months post randomization (December 2017-June 2022), with analyses performed in 2024. TTM2 was an international, multicenter study conducted at 61 hospitals in 14 countries. The study included 1861 adults with OHCA of presumed cardiac or unknown cause who were initially comatose. There were 992 survivors at 1 month, 943 at 6 months, and 835 at 24 months. Nonparticipation rates at follow-up were 44 (4%), 107 (11%), and 165 (20%), respectively.

INTERVENTION: Participants were randomized 1:1 to undergo temperature control via targeted hypothermia (33 °C) or targeted normothermia and early treatment of fever (≥37.8 °C).

MAIN OUTCOMES AND MEASURES: The functional outcome, including societal participation, was assessed using the Glasgow Outcome Scale-Extended (GOSE). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and the Symbol Digit Modalities Test (SDMT).

RESULTS

Of the participants who were followed up, 84% were male, with a mean (SD) age of 60 (14) years, and clinical variables were similar between the hypothermia and normothermia temperature groups. No significant differences were found between temperature groups regarding societal participation (GOSE: odds ratio, 0.97 [95% CI, 0.72-1.30]) or cognitive function (MoCA: mean difference, -0.02 [95% CI, -0.67 to 0.63]; SDMT: mean difference, -0.09 [95% CI, -0.33 to 0.16]) at 24 months. Improvement for GOSE was significant within the first 6 months (1 to 6 months: n = 1707 [95% CI, -2.00 to -1.50]; P < .001; 6 to 24 months: n = 1606 [95% CI, -0.50 to <0.001]; P = .10). Intraindividual improvement and decline corresponding to thresholds for minimal important differences were observed for societal participation and cognitive function up to 24 months.

CONCLUSIONS AND RELEVANCE: Targeted hypothermia, compared with targeted normothermia, did not affect societal participation or cognitive function at 24 months, suggesting no longer-term effect of hypothermia for the explored outcomes. The intraindividual changes observed indicate variability in recovery.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02908308.

Для цитирования: Hultgren Malin, Blennow Nordström Erik, Ullén Susann, Nielsen Niklas, Dankiewicz Josef, Jakobsen Janus Christian, Heimburg Katarina, Moseby-Knappe Marion, Belohlávek Jan, Bohm Mattias, Cariou Alain, Eastwood Glenn, Friberg Hans, Grejs Anders M, Hammond Naomi, Hänggi Matthias, Hrecko Juraj, Iten Manuela, Keeble Thomas R, Leithner Christoph, Levin Helena, Mion Marco, Rylander Christian, Schrag Claudia, Thomas Matthew, Wise Matt P, Young Paul, Cronberg Tobias, Lilja Gisela. Long-Term Outcomes and Recovery Trajectories in Out-of-Hospital Cardiac Arrest: A 2-Year Follow-Up of the Randomized Clinical TTM2 Trial.. JAMA neurology. 2026. DOI: 10.1001/jamaneurol.2025.5614.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.